XML 80 R13.htm IDEA: XBRL DOCUMENT v3.24.0.1
Investments
12 Months Ended
Dec. 31, 2023
Investments, Debt and Equity Securities [Abstract]  
Investments Investments
Debt Securities
The Company’s investments in debt securities consisted of the following as of December 31, 2023 and 2022 (in thousands):
December 31, 2023
 CostGross
Unrealized
Gains
Gross
Unrealized
Losses
Fair Value
U.S. treasury securities$86,764 $20 $— $86,784 
U.S. agency and government sponsored securities2,732 — — 2,732 
Commercial paper10,144 — — 10,144 
Corporate bonds44,924 (27)44,906 
Total debt securities$144,564 $29 $(27)$144,566 
Included in cash and cash equivalents$1,595 $— $(1)$1,594 
Included in marketable securities$142,969 $29 $(26)$142,972 
December 31, 2022
 CostGross
Unrealized
Gains
Gross
Unrealized
Losses
Fair Value
U.S. treasury securities$191,075 $$(2,598)$188,480 
U.S. agency and government sponsored securities4,999 — (75)4,924 
Commercial paper74,755 — (232)74,523 
Corporate bonds111,123 — (1,214)109,909 
Asset-backed securities11,945 — (110)11,835 
Total debt securities$393,897 $$(4,229)$389,671 
Included in marketable securities$393,897 $$(4,229)$389,671 
The following table presents the gross unrealized losses and the fair value for those debt securities that were in an unrealized loss position for less than 12 months as of December 31, 2023 and 2022 (in thousands):
December 31, 2023December 31, 2022
Gross
Unrealized
Losses
Fair ValueGross
Unrealized
Losses
Fair Value
U.S. treasury securities$— $— $(2,598)$158,888 
U.S. agency and government sponsored securities— 741 (75)4,924 
Commercial paper— — (232)74,523 
Corporate bonds(27)30,621 (1,214)109,909 
Asset-backed securities— — (110)11,835 
Total$(27)$31,362 $(4,229)$360,079 
Equity Investments
The Company’s equity investments consisted of the following as of December 31, 2023 and 2022 (in thousands):
December 31,
Consolidated Balance Sheets Location20232022
Money market funds(1)
Cash and cash equivalents$101,842 $42,056 
Marketable equity investments(1)
Marketable securities7,755 29,643 
Investment in non-marketable securities(2)
Other non-current assets10,000 — 
Non-marketable equity investment measured using the measurement alternative(2)
Other non-current assets4,000 4,000 
$123,597 $75,699 
(1)    Investments with readily determinable fair values.
(2)    Investment in privately held company without readily determinable fair value.
In December 2021, the Company made an investment in 1,495 Class A Preferred Units of Robotic Research OpCo, LLC (“Robotic Research”) for consideration of $10.0 million, which was settled by issuing 618,924 shares of Class A common stock of the Company. The Company’s investment in Robotic Research represents less than 5% of Robotic Research’s capitalization. The Company neither has a significant influence over Robotic Research nor does its investment amount to a controlling financial interest in Robotic Research. As such, the Company measured the initial investment in Robotic Research at cost as provided under the guidance for measurement of equity investment using the measurement alternative. In the fourth quarter of 2022, the Company recorded an impairment charge of $6.0 million related to the investment in Robotic Research.
In December 2022, the Company made an investment in 1,500,000 Class A ordinary shares of ECARX Holdings Inc., (“ECARX”) for consideration of $15.0 million, which was settled by issuing 2,030,374 shares of Class A common stock of the Company. The Company’s investment in ECARX represents less than 5% of ECARX’s capitalization. The Company neither has a significant influence over ECARX nor does its investment amount to a controlling financial interest in ECARX. The Company measured the investment in ECARX using the quoted prices in active markets with changes recorded in other income (expense), net on the consolidated statement of operations. Jun Hong Heng is a director of ECARX. Mr. Heng is also a director of Luminar.
In August 2023, the Company made an investment in a Simple Agreement for Future Equity (“SAFE”) of Plus Automation, Inc. (“Plus”) for consideration of $10.0 million, towards which the Company initially issued 1,490,313 shares of Class A common stock of the Company. In September 2023, the Company settled the consideration owed by issuing an additional 436,158 shares of Class A common stock. The Company’s investment in Plus represents less than 5% of Plus’s capitalization. The Company neither has a significant influence over Plus nor does its investment amount to a controlling financial interest in Plus.